The Silver Book: Chronic Disease and Medical Innovation in an Aging Nation

E-Alert

RSS Feed

Home > Innovative Medical Research > Vision Loss > The Economic Value

There are 7 facts in this category.

Treatments that have been found to delay or prevent diabetic retinopathy save the U.S. $1.6 billion annually.
---
Research to Prevent Blindness. "Diabetic Retinopathy". [ Permalink ]

The cost-effectiveness of detection and treatment of eye disease in diabetics is $3,190 per quality adjusted life year (QALY).
---
Javitt, Jonathan C., and Lloyd Paul Aiello. "Cost-Effectiveness of Detecting and Treating Diabetic Retinopathy". Annals of Internal Medicine. Vol. 124, No. 1, pp. 164-9. [ Permalink ]

Screening and treatment of diabetic retinopathy in type 2 diabetes patients produces annual savings of $247.9 million to the federal budget-- in 1994 dollars.
---
Javitt, Jonathan C., Lloyd Paul Aiello, Yen-Pin Chiang, and S. Greenfield. "Preventive Eye Care in People With Diabetes is Cost-Saving to the Federal Government: Implications for health care reform". Diabetes Care. Vol. 17, No. 8, pp. 909-17. [ Permalink ]

Of the 8 million older Americans at high risk of developing advanced age-related macular degeneration (AMD), 1.3 million will develop advanced AMD within 5 years. However, the NEI-sponsored Age-Related Eye Disease Study (AREDS) nutritional formula could help 300,000 of those 1.3 million avoid the severe vision loss of advanced AMD over a 5-year period.
---
Bressler, Neil M., Susan B. Bressler, Nathan G. Congdon, Frederick L. Ferris III, David S. Friedman, Ronald Klein, Anne S. Lindblad, Roy C. Milton, and Johanna M. Seddon . "Potential Public Health Impact of Age-Related Eye Disease Study Results: AREDS report no. 11". Archives of Ophthalmology. Vol. 121, No. 11, pp. 1621-4. [ Permalink ]

Screening and treatment for eye disease in all type 2 diabetes patients would result in an estimated net savings of over $472.1 million-- in 1994 dollars.
---
Javitt, Jonathan C., Lloyd Paul Aiello, Yen-Pin Chiang, and S. Greenfield. "Preventive Eye Care in People With Diabetes is Cost-Saving to the Federal Government: Implications for health care reform". Diabetes Care. Vol. 17, No. 8, pp. 909-17. [ Permalink ]

Screening and treatment for eye disease in all type 2 diabetes patients would result in an estimated net savings of 94,304 person-years of sight.
---
Javitt, Jonathan C., Lloyd Paul Aiello, Yen-Pin Chiang, and S. Greenfield. "Preventive Eye Care in People With Diabetes is Cost-Saving to the Federal Government: Implications for health care reform". Diabetes Care. Vol. 17, No. 8, pp. 909-17. [ Permalink ]

Because the resource use and direct cost of glaucoma treatment and management increases as the disease severity worsens-- from an average $623 per early-stage patient to $2,511 per late-stage patient-- a glaucoma treatment that delays the disease progression could significantly reduce its economic burden.
---
Lee, Paul P., John G. Walt, John L. Doyle, Sameer V. Kotak, Stacy J. Evans, Donald L. Budenz, Philip P. Chen, Anne L. Coleman, Robert M. Feldman, Henry D. Jampel, L. Jay Katz, Richard P. Mills, Jonathan S. Myers, Robert J. Noecker, et al. "A Multicenter, Retrospective Pilot Study of Resource Use and Costs Associated with Severity of Disease in Glaucoma". Archives of Ophthalmology. Vol. 124, No. 1, pp. 12-9. [ Permalink ]